Poster Abstract Session:
78. Vaccines: Pneumococcal
Thursday, October 27, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Adult ID

Presentations:
773
Cost-Effectiveness Of The 13-Valent (PCV13) Versus 10-Valent (PCV10) Pneumococcal Conjugate Vaccines As Part Of Routine Infant Pneumococcal Vaccination In Mexico
Matt Wasserman, MSc ; Carlos Fernando Mendoza, Pharm D. MSc ; Ana Gabriela Grajales, MD ; Maria Gabriela Palacios, MD ; Manuela Di Fusco, B.Ec, MSc
774
Trends in Pediatric Pneumococcal Pleural Empyema following Pneumococcal Conjugate 13-Valent Vaccination: 10 Years of Active Surveillance in a Mexican Hospital
Enrique Chacon-Cruz, MD ; Erika Zoe Lopatynsky-Reyes, MD ; Rosa Maria Rivas-Landeros, PhD ; Maria Luisa Volker-Soberanes, PhD ; Jorge Arturo Alvelais-Palacios, MD, PhD
Posters
  • eposterchaconetal.pdf (481.0 kB)
    • 775
    Streptococcus pneumoniae nasopharyngeal carriage rates, serotype distribution and vaccine effectiveness in vaccinated and non-vaccinated healthy children in Guatemala City.
    Mario Melgar, MD ; Isabel Perez, MD ; Rene Ordoñez, MD ; Irwin Paniagua, MD ; Claudia Vargas, Lic
    Posters
  • POSTER IDWEEK 2016 MELGAR.pdf (614.3 kB)
    • 776
    Effectiveness of pneumococcal conjugate vaccine -PCV10- in a city of the Colombian Caribbean: case-control study nested in a cohort.
    Wilfrido Coronell-Rodríguez, PhD (C) Tropical Medicine ; Cindy Arteta-Acosta, Student Master of Epidemiology ; Steven Osorio-Anaya, Resident of Otolaryngology ; Saabad Mejia-Bermudez, Student Medicine ; Fernando De La Hoz, PhD ; Nelson Alvis-Guzman, PhD
    Posters
  • IDWeek. Poster Efectividad2.pdf (826.8 kB)
    • 777
    The Impact of PCV7/PCV13 Implementation on Acute Bacterial Conjunctivitis (ABC) in Children <2 Years in Southern Israel: A Population-Based 11 Years Prospective Study
    Ron Dagan, MD ; David Greenberg, MD, FIDSA ; Doreen Ozalvo, MD ; Noga Givon-Lavi, PhD
    778
    Vaccine-Type Pneumococcal Disease (IPD) and Patterns of Penicillin and Cefotaxime Non-Susceptibility Following Routine Use of 13-Valent Conjugate Pneumococcal Infant Vaccination in the United States
    Jose Suaya, MD, PhD ; Heather Sings, PhD ; Alvaro Quintana, MD ; Raul Isturiz, MD
    Posters
  • 778.Suaya.pdf (711.1 kB)
    • 779
    Emergence of PCV13 nonvaccine-specific Streptococcus pneumoniae serogroups 15, 23, 33, and 35 isolated from children in Kansas City, Missouri
    Douglas Swanson, MD ; Christopher J. Harrison, M.D., FAAP, FPIDS ; Maria J Tort, PhD ; Angee Mcdaniel, PharmD
    Posters
  • PCV13 nonvaccine-specific strains.pdf (285.3 kB)
    • 780
    Impact of Streptococcus pneumoniae in Acute Otitis Media (AOM) with Spontaneous Tympanic Membrane Perforation (sTMP): Serotype Distribution 4 Years After 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Introduction
    Susanna Esposito, MD ; Paola Marchisio, MD ; Calogero Sathya Sciarrabba, MD ; Elwna Baggi, MD ; Erica Nazzari, MD ; Leonardo Terranova, Bsc ; Nicola Principi, MD
    Posters
  • poster 780 pneumo ST in AOM 131016.pdf (662.6 kB)
    • 781
    Invasive Pneumococcal Disease, before and After Implementation of the Conjugate Vaccine in Israel: a multi-center retrospective study.
    Hanna Kletzel, MD ; Gideon Paret, Prof. ; Avihu Bar Yochai, MD ; David Schwartz, PhD ; Galia Grisaru-Soen, MD
    782
    Factors associated with Rotavirus vaccine (RVV) uptake among US children 8 months to 5 years old, 2014-2015
    Negar Aliabadi, MD MS ; Mary E. Wikswo, MPH ; Jacqueline Tate, PhD ; Umesh D. Parashar, MBBS, MPH ; Daniel Payne, PhD, MSPH
    783
    Invasive Pneumococcal Disease (IPD), Antibiotic Use, and Patterns of Penicillin and Cefotaxime Non-Susceptibility Following Routine Use of 13-Valent Conjugate Pneumococcal Infant Vaccination in the United States
    Jose Suaya, MD, PhD ; Shirley Fung, MMR ; John Scaife, MS ; Alvaro Quintana, MD ; Raul Isturiz, MD
    Posters
  • 783.Suaya.pdf (499.4 kB)
    • 784
    Clinical and Economic Burden of Pneumococcal Disease in Adults 19-64 Years with Chronic Conditions in the United States
    H. Keri Yang, PhD, MPH, MS ; Dongmu Zhang, PhD ; Panagiotis Mavros, PhD ; Tanaz Petigara, PhD
    Posters
  • kavaspet_192273-0001-ID_Week_Poster-1_Chronic_v1.02.pdf (329.0 kB)
    • 785
    Clinical and Economic Burden of Pneumococcal Disease in Adults 19-64 Years with Immunocompromising Conditions in the United States
    H. Keri Yang, PhD, MPH, MS ; Dongmu Zhang, PhD ; Panagiotis Mavros, PhD ; Tanaz Petigara, PhD
    Posters
  • kavaspet1_92302-0001-ID_Week_Poster-2_Immune_v1.02.pdf (234.7 kB)
    • 786
    Serotype Distributions and Analysis of Susceptibility Profiles of Streptococcus pneumoniae Causing Infections in Adult Patients in the United States (2009-2013)
    Rodrigo E. Mendes, PhD ; Sarah E. Costello, BS ; Heather Sings, PhD ; Robert K. Flamm, Ph.D. ; Raúl E. Isturiz, MD
    Posters
  • 786.Mendes.pdf (1.4 MB)
    • 787
    Interim analysis of a randomized, open-label, parallel design study to compare the immunogenicity of simultaneous administration versus sequential administration of quadrivalent influenza vaccine and 23-valent polysaccharide pneumococcal vaccine
    Kei Nakashima, M.D. ; Masahiro Aoshima, M.D. Ph.D. ; Satoko Ohfuji, M.D. Ph.D. ; Satoshi Yamawaki, M.D. ; Masahiro Nemoto, M.D. ; Shinya Hasegawa, M.D. ; Satoshi Noma, M.D. ; Masafumi Misawa, M.D. Ph.D. ; Naoto Hosokawa, M.D. ; Makito Yaegashi, M.D. ; Yoshihito Otsuka, Ph.D.
    Posters
  • 2016 IDSA 787 kei nakashima .pdf (340.1 kB)
    • 788
    Continued Presence of Multi-resistant (Non-vaccine) Serotype 15A in Both Invasive and Respiratory Streptococcus pneumoniae Infections in the UK and Ireland
    Veronique Martin, PhD ; Shazad Mushtaq, MSc
    789
    Serotypes and Antimicrobial Resistance of Isolates Causing Invasive Pneumococcal Disease in Adult Patients in Portugal After the 13-Valent Conjugate Vaccine Received an Adult Indication - 2012-2014
    Andreia N. Horácio, MSc ; Catarina Silva-Costa, PhD ; Joana P Lopes, MSc ; Mario Ramirez, PhD ; Jose Melo-Cristino, MD, PhD
    Posters
  • 267_IDWPOSTER_sec.pdf (889.2 kB)
    • 790
    Risk Stacking of Pneumococcal Vaccination Indications Increases Mortality in Unvaccinated Adults with Streptococcus pneumoniae Infections
    Jacob Morton, PharmD, MBA, BCPS ; Haley Morrill, PharmD ; Kerry Laplante, Pharm.D., FCCP ; Aisling Caffrey, PhD, MS
    791
    Incidence of acute otitis media in the vaccines era against pneumococcus in a city of the Colombia Caribbean Coast: a cohort study.
    Wilfrido Coronell-Rodríguez, PhD (C) Tropical Medicine ; Cindy Arteta-Acosta, Student Master of Epidemiology ; Steven Osorio-Anaya, Resident of Otolaryngology ; Fernando De La Hoz, PhD ; Nelson Alvis-Guzman, PhD
    Posters
  • IDWeek. Poster incidencia2.pdf (814.1 kB)

    • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.